Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Neuropharmacology
|
September 21, 2020
The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology
Renee A Rotolo, Rose E Presby, Olivia Tracy, et al.
Journal of Natural Products
|
September 15, 2017
Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression
Samantha E Yohn, Dea Gorka, Anisha Mistry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 25, 2015
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
Samantha E Yohn, Samantha L Collins, Hector M Contreras-Mora, et al.
Neuropharmacology
|
June 23, 2016
Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology
Samantha E Yohn, Emily E Errante, Aaron Rosenbloom-Snow, et al.
Psychopharmacology
|
June 6, 2024
Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats
Alev Ecevitoglu, Kathryn R Beard, Sonia Srynath, et al.
Psychopharmacology
|
August 24, 2023
Effort-related effects of chronic administration of the DA D<sub>2</sub> receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline
Renee A Rotolo, Alev Ecevitoglu, Rose E Presby, et al.
Cognitive, Affective & Behavioral Neuroscience
|
December 4, 2025
Theta oscillations vary with local response rate and are moderated by the dopamine-depleting agent, tetrabenazine, during effort-based behavior
Alev Ecevitoglu, Abhijith Mankili, Naixin Ren, et al.
Pharmacology, Biochemistry, and Behavior
|
June 29, 2020
Effort-related decision making in humanized COMT mice: Effects of Val<sup>158</sup>Met polymorphisms and possible implications for negative symptoms in humans
Jen-Hau Yang, Rose E Presby, Suzanne Cayer, et al.
Neuropharmacology
|
February 10, 2025
Effort-related motivational effects of methylphenidate: Reversal of the low-effort bias induced by tetrabenazine and enhancement of progressive ratio responding in male and female rats
Alev Ecevitoglu, Renee A Rotolo, Gayle A Edelstein, et al.
Psychopharmacology
|
June 26, 2023
Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition
Alev Ecevitoglu, Gayle A Edelstein, Rose E Presby, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Neuropharmacology
|
September 21, 2020
The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology
Renee A Rotolo, Rose E Presby, Olivia Tracy, et al.
Journal of Natural Products
|
September 15, 2017
Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression
Samantha E Yohn, Dea Gorka, Anisha Mistry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 25, 2015
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
Samantha E Yohn, Samantha L Collins, Hector M Contreras-Mora, et al.
Neuropharmacology
|
June 23, 2016
Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology
Samantha E Yohn, Emily E Errante, Aaron Rosenbloom-Snow, et al.
Psychopharmacology
|
June 6, 2024
Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats
Alev Ecevitoglu, Kathryn R Beard, Sonia Srynath, et al.
Psychopharmacology
|
August 24, 2023
Effort-related effects of chronic administration of the DA D<sub>2</sub> receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline
Renee A Rotolo, Alev Ecevitoglu, Rose E Presby, et al.
Cognitive, Affective & Behavioral Neuroscience
|
December 4, 2025
Theta oscillations vary with local response rate and are moderated by the dopamine-depleting agent, tetrabenazine, during effort-based behavior
Alev Ecevitoglu, Abhijith Mankili, Naixin Ren, et al.
Pharmacology, Biochemistry, and Behavior
|
June 29, 2020
Effort-related decision making in humanized COMT mice: Effects of Val<sup>158</sup>Met polymorphisms and possible implications for negative symptoms in humans
Jen-Hau Yang, Rose E Presby, Suzanne Cayer, et al.
Neuropharmacology
|
February 10, 2025
Effort-related motivational effects of methylphenidate: Reversal of the low-effort bias induced by tetrabenazine and enhancement of progressive ratio responding in male and female rats
Alev Ecevitoglu, Renee A Rotolo, Gayle A Edelstein, et al.
Psychopharmacology
|
June 26, 2023
Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition
Alev Ecevitoglu, Gayle A Edelstein, Rose E Presby, et al.
Page
of 4